| Schedule of earnings per share, basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Nine
Months Ended
September 30, |
|
|
Three
Months Ended
September 30, |
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Weighted-average common shares outstanding
– basic |
|
|
23,867,204 |
|
|
|
23,830,702 |
|
|
|
23,803,567 |
|
|
|
23,765,089 |
|
| Dilutive effect of restricted stock units and stock
options |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
300,635 |
|
| Weighted-average common shares outstanding – diluted |
|
|
23,867,204 |
|
|
|
23,830,702 |
|
|
|
23,803,567 |
|
|
|
24,065,724 |
|
| Restricted stock units excluded from the computation
of diluted loss per share because the effect of inclusion would have been anti-dilutive |
|
|
598,750 |
|
|
|
1,148,750 |
|
|
|
598,750 |
|
|
|
— |
|